PBI-1393
PBI-1393 (BCH-1393) is an anticancer agent that enhances Th1 type cytokine production and primary T cell activation[1].
Product Specifications
CAS Number
175072-12-5
Product Name Alternative
BCH-1393
UNSPSC
12352005
Target
TNF Receptor
Type
Reference compound
Related Pathways
Apoptosis
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/pbi-1393.html
Smiles
N=C(NCCC[C@@H](NC(OCCCCCN1C=NC2=C(N=CN=C12)N(C)C)=O)C(O)=O)N
Molecular Formula
C19H31N9O4
Molecular Weight
449.51
References & Citations
[1]Mustapha Allam, et al. Enhancement of Th1 type cytokine production and primary T cell activation by PBI-1393. Clin Immunol. 2007 Dec;125 (3) :318-27.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
AAF-014-1 1 mL
Alkaline Phosphatase Conjugated Swine Affinity Purified Antibody to Goat IgG,
Sign In for Pricing
View Details 